Larry LaPointe

Title: Larry LaPointe: Innovator in Chromatographic Assay Technology

Introduction

Larry LaPointe is a notable inventor based in Ryde, Australia. He has made significant contributions to the field of chromatographic assay devices, particularly in the detection of analytes in whole blood samples. His innovative work has led to the development of a unique device that enhances the sensitivity and reliability of immunoassays.

Latest Patents

Larry LaPointe holds a patent for an "Opposable-element chromatographic assay device for detection of analytes in whole blood samples." This device features a unidirectional immunoassay that improves sensitivity and reduces interference. The design includes a sample application zone with a porous matrix that traps cellular components while allowing the liquid portion of blood to pass through. The chromatographic medium consists of a detection zone with a specific binding partner for the analyte and a conjugate zone with a labeled binding partner. The device is designed for operable contact between its components, facilitating the application of wash liquid and enhancing assay performance.

Career Highlights

Larry LaPointe is associated with Beckman Coulter, Inc., a company known for its advancements in laboratory instruments and reagents. His work at Beckman Coulter has allowed him to focus on developing innovative solutions that address critical needs in medical diagnostics.

Collaborations

Throughout his career, Larry has collaborated with notable colleagues, including Daniel Joseph Fitzgerald and Howard Milne Chandler. These collaborations have contributed to the advancement of technologies in the field of assay devices.

Conclusion

Larry LaPointe's contributions to chromatographic assay technology exemplify the impact of innovation in medical diagnostics. His patented device represents a significant advancement in the detection of analytes, showcasing his commitment to improving healthcare solutions.